16-19861855-G-A
Position:
Variant summary
Our verdict is Benign. Variant got -19 ACMG points: 0P and 19B. BP4_ModerateBP6_Very_StrongBP7BS1BS2
The NM_016235.3(GPRC5B):c.1149C>T(p.Val383Val) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00384 in 1,613,292 control chromosomes in the GnomAD database, including 91 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.015 ( 35 hom., cov: 32)
Exomes 𝑓: 0.0027 ( 56 hom. )
Consequence
GPRC5B
NM_016235.3 synonymous
NM_016235.3 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.339
Genes affected
GPRC5B (HGNC:13308): (G protein-coupled receptor class C group 5 member B) This gene encodes a member of the type 3 G protein-coupled receptor family. Members of this superfamily are characterized by a signature 7-transmembrane domain motif. The encoded protein may modulate insulin secretion and increased protein expression is associated with type 2 diabetes. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Feb 2015]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -19 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.37).
BP6
Variant 16-19861855-G-A is Benign according to our data. Variant chr16-19861855-G-A is described in ClinVar as [Benign]. Clinvar id is 769895.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=0.339 with no splicing effect.
BS1
Variant frequency is greater than expected in population afr. gnomad4 allele frequency = 0.0145 (2205/152068) while in subpopulation AFR AF= 0.0397 (1646/41460). AF 95% confidence interval is 0.0381. There are 35 homozygotes in gnomad4. There are 1172 alleles in male gnomad4 subpopulation. Median coverage is 32. This position pass quality control queck.
BS2
High AC in GnomAd4 at 2205 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
GPRC5B | NM_016235.3 | c.1149C>T | p.Val383Val | synonymous_variant | 3/4 | ENST00000300571.7 | NP_057319.1 | |
GPRC5B | NM_001304771.1 | c.1542C>T | p.Val514Val | synonymous_variant | 3/4 | NP_001291700.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
GPRC5B | ENST00000300571.7 | c.1149C>T | p.Val383Val | synonymous_variant | 3/4 | 1 | NM_016235.3 | ENSP00000300571.2 |
Frequencies
GnomAD3 genomes AF: 0.0145 AC: 2204AN: 151950Hom.: 35 Cov.: 32
GnomAD3 genomes
AF:
AC:
2204
AN:
151950
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00675 AC: 1696AN: 251438Hom.: 32 AF XY: 0.00587 AC XY: 798AN XY: 135898
GnomAD3 exomes
AF:
AC:
1696
AN:
251438
Hom.:
AF XY:
AC XY:
798
AN XY:
135898
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00273 AC: 3992AN: 1461224Hom.: 56 Cov.: 30 AF XY: 0.00247 AC XY: 1792AN XY: 726920
GnomAD4 exome
AF:
AC:
3992
AN:
1461224
Hom.:
Cov.:
30
AF XY:
AC XY:
1792
AN XY:
726920
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0145 AC: 2205AN: 152068Hom.: 35 Cov.: 32 AF XY: 0.0158 AC XY: 1172AN XY: 74344
GnomAD4 genome
AF:
AC:
2205
AN:
152068
Hom.:
Cov.:
32
AF XY:
AC XY:
1172
AN XY:
74344
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
17
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Mar 19, 2018 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at